Citation: | Xue Lexun, . Effects of dietary calcium and vitamin D on induced epithelial hyperproliferation in mouse mammary gland by a high-fat diet[J]. Cancer Research on Prevention and Treatment, 1998, 25(6): 451-454. |
1 Nationl Center for Health Statistics;US Dept. Health Human Services,1990.172:4~60
|
2 Xue I_X. Newmark HI,I_ipkin M. Mammary gland hyperproliferation and hyperplasia induced in mice by a Western-style diet. Cancer Res,1995.36:596
|
3 Xue LX. Newmark HI,I_ipkin M. Model of mouse mammary gland hyperproliferation and hyperplasia induced by a Western-style diet. Nutr Cancer. 1996.26:281~287
|
4 Newmark HI,Lipkin M. Maheswari N. Colonic hyperplasia and hyperproliferation induced by a nutritional stress diet with four components of Westen-style diet. J Natl Cancer Inst. 1990. 82:491~496
|
5 Newmark HI_. I_ipkin M. Maheswari N. Colonic hyperproliferation induced in rats and mice by nutritional stress diets containing four components of a human Westernstyle diet (series 2). Am J Clin Nutr. 1991.54:209~214s
|
6 Lipkin M. Newmark HI.Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Eng J Med. 1985,313: 1381~1384
|
7 Ad Hoc Committee on standards for nutritional studies.Report of the American Institute of Nutrition Ad Hoc Committee on standards for nutritional studies. J Nutr. 1977. 107:1324~1434
|
8 Wellings SR. ]ensen HM. On the origin and progression of ductal carcinoma in the human breast.J Natl Cancer Inst.1973. 50;1111~1118
|
9 Wellings SR. Jensen HM. Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst,1975,55:231~273
|
10 Zhang I_. Bird RP. Bruce WR. Proliferative activity of murine mammary epithelium as affected by dietary fat and calcium. Cancer Res. 1987,47:4905~4908
|
11 Carroll KK. Khor HT. Dietary fat in relation to tumorigenesis. Prog Biochem Pharmacol. 1975.10:308~353
|
12 Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975.15:617~631
|
13 Welsch CW. House ]I,Herr Bl,et al. Enhancement of mammary carcinogenesis by high levels of dietary fat: A phenomenon dependent on ad libitum feeding. J Natl Cancer Inst. 1990. 82:1615~1620
|
14 Hopkins GJ,Carroll KK. Relationship between amount and type of dietary fat in promotion of mammary carcinogenesis induced by 7. 12-dimethylbenz (a ) anthracene. J Natl Cancer Inst.1979. 62:1009~1012
|
15 Newmark HI,Wargovich S. Bruce WR. Colon cancer and dietary fat,phosphates and calcium; A hypothesis.J Natl Cancer Inst. 1984.72:1323~1325
|
16 Xue I_X, Newmark HI,Leung D. Epithelial cell hyperproliferation induced in the exocrine pancreas of mice by a Western-style diet. J Natl Cancer Inst. 1996.88;1586~1590
|
17 Xue I_X, I_ipkin M. Newmark Hl.Induced hyperpoliferanon in epithelial cells of mouse prostate by a Westernstyle diet. Carcinogenesis,1997. 18:995~999
|
18 Colston KW. Berger U, Combes RC. Possible role for vitamin D in controlling breast cancer cell proliferation.Lancet, 1989,1:188~191
|
19 Koga M,Eisman JA. Sutherland RI_. Regulation of epidermal growth factor receptor levels by 1.25-dihydroxyvitamin Da in human bresat cancer cells. Cancer Res. 1988.48:2734~2739
|
[1] | JIANG Wenxin, LIU Peng. Cancer Immunotherapy and Abnormal Lipid Metabolism[J]. Cancer Research on Prevention and Treatment, 2025, 52(5): 355-360. DOI: 10.3971/j.issn.1000-8578.2025.24.1253 |
[2] | ZHENG Yu, PAN Hongming. Progress of Targeted Therapy and Immunotherapy for Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2024, 51(4): 234-239. DOI: 10.3971/j.issn.1000-8578.2024.23.1257 |
[3] | ZHOU Wence, ZHANG Hui, LI Xin, DONG Shi. Frontier and Future of Immunotherapy for Pancreatic Cancer[J]. Cancer Research on Prevention and Treatment, 2023, 50(4): 338-344. DOI: 10.3971/j.issn.1000-8578.2023.22.1290 |
[4] | WU Wei, JING Doudou, CAO Li, PU Feifei, SHAO Zengwu. Current Status and Prospects of Immunotherapy for Osteosarcoma[J]. Cancer Research on Prevention and Treatment, 2022, 49(7): 721-726. DOI: 10.3971/j.issn.1000-8578.2022.21.1281 |
[5] | CHEN Weichang, SHI Tongguo, ZHU Jinghan, SUN Linqing, LI Juntao. Progress on Immunotherapy of Gastrointestinal Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(7): 639-643. DOI: 10.3971/j.issn.1000-8578.2022.21.1527 |
[6] | SUN Lu, SHI Hongwei, PI Guoliang. Advances in Molecular Targeting and Immunotherapy on Angiosarcomas[J]. Cancer Research on Prevention and Treatment, 2022, 49(1): 62-66. DOI: 10.3971/j.issn.1000-8578.2022.21.1045 |
[7] | ZHOU Li, SHENG Xi'nan. Progress and Comment on Immunotherapy of Advanced Renal Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2020, 47(3): 149-153. DOI: 10.3971/j.issn.1000-8578.2020.19.1519 |
[8] | YANG Kang, LI Youyuan, YU Junfeng, WEI Shaozhong. Updates of Immunotherapy on Renal Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2015, 42(09): 929-932. DOI: 10.3971/j.issn.1000-8578.2015.09.015 |
[9] | ZHANG Yanli, ZHU Shunqin, LIU Yaling, CUI Hongjuan. 恶性黑色素瘤内科治疗研究进展[J]. Cancer Research on Prevention and Treatment, 2014, 41(01): 74-78. DOI: 10.3971/j.issn.1000-8578.2014.01.017 |
[10] | Wang Li, Gao Quanli, Wang Zibing, Fu Xiaomin, Zhang Xiaojie, Xu Benling, Zhang Xuhua, Zhang Yong, Yang Yonghao, Liu Yuqing, Song Yongping. Clinical Efficacy of Autologous CIK Cell Adoptive Immunotherapy Combined with Chemotherapy in Patients Withmetastatic Renal Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2012, 39(06): 722-724. DOI: 10.3971/j.issn.1000-8578.2012.06.028 |